possible link between atypical antipsychotics and diabetes

You'll see more attention focused on the possible link between atypical antipsychotics and diabetes.

FDA and drug companies will battle out new labeling requirements for warnings about diabetes risks in patients taking atypicals.

The FDA wants the warnings to apply to ALL atypicals. But some companies don't think their drug needs the new warning at all.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote